US OptionsDetailed Quotes
UBER241213C83000
- 0.08
- 0.000.00%
15min DelayClose Dec 13 16:00 ET
0.00High0.00Low
0.08Open0.08Pre Close0 Volume568 Open Interest83.00Strike Price0.00Turnover5911.43%IV38.63%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.08Extrinsic Value100Contract SizeAmericanOptions Type0.0237Delta0.0059Gamma749.13Leverage Ratio-92.9026Theta0.0000Rho17.76Eff Leverage0.0001Vega
Uber Technologies Stock Discussion
Sign in to post a comment
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...
+2
9
1
4
$Uber Technologies (UBER.US)$ robotaxi will kill Uber
1
1
$Uber Technologies (UBER.US)$ how can this stock get any lower?!
1
1
$Uber Technologies (UBER.US)$ bankruptcy
1
1
$Uber Technologies (UBER.US)$ and Adobe, beat the estimates but no bright future? ugh
1
2
$Uber Technologies (UBER.US)$ the laughing stock of the stock market
$Uber Technologies (UBER.US)$ this stock is donezo. tesla and waymo will eat all of its demand up. best short target
$Uber Technologies (UBER.US)$ best stock for 2025 to buy puts on - Goldman Sachs
1
No comment yet
10xStockPicks OP : This is the correctly edited research report. Previous article has a few typos. Special thanks to Fund manager John for his notes. Please do your own research. I firmly believe ESPR will be a solid bet.